Clinical Trial Update: Adverse Neonatal Outcomes With a Shortened Clinical Regimen of Dexamethasone. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a shortened dexamethasone regimen for preterm birth reports adverse neonatal outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth
• Respiratory Distress Syndrome

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Ricardo A Gutierrez Ramirez, MD, MSc, FACOG | Conditions: Preterm Birth, Distress Respiratory Syndrome | Phase 2 | Status: COMPLETED